BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21891868)

  • 1. Gene signature in Alzheimer's disease and environmental factors: the virus chronicle.
    Licastro F; Carbone I; Ianni M; Porcellini E
    J Alzheimers Dis; 2011; 27(4):809-17. PubMed ID: 21891868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease gene signature says: beware of brain viral infections.
    Porcellini E; Carbone I; Ianni M; Licastro F
    Immun Ageing; 2010 Dec; 7():16. PubMed ID: 21156047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three new pathways leading to Alzheimer's disease.
    Morgan K
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):353-7. PubMed ID: 21486313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.
    Carter CJ
    Neurosci Lett; 2010 Oct; 483(2):96-100. PubMed ID: 20674675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.
    Carter CJ
    Neurochem Int; 2008 May; 52(6):920-34. PubMed ID: 18164103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations].
    Golenkina SA; Gol'tsov AIu; Kuznetsova IL; Grigorenko AP; Andreeva TV; Reshetov DA; Kunizheva SS; Shagam LI; Morozova IIu; Goldenkova-Pavlova IV; Shimshilashvili Kh; Viacheslavova AO; Faskhutdinova G; Gareeva AÉ; Zaĭnullina AG; Khusnutdinova ÉK; Puzyrev VP; Stepanov VA; Kolotvin AV; Samokhodskaia LM; Selezneva ND; Gavrilova SI; Rogaev EI
    Mol Biol (Mosk); 2010; 44(4):620-6. PubMed ID: 20873220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies.
    Misra A; Chakrabarti SS; Gambhir IS
    Indian J Med Res; 2018 Aug; 148(2):135-144. PubMed ID: 30381536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
    Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
    Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
    Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
    Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
    Wozniak MA; Mee AP; Itzhaki RF
    J Pathol; 2009 Jan; 217(1):131-8. PubMed ID: 18973185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
    Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
    Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of Alzheimer's disease: new evidences for an old hypothesis?
    Lambert JC; Amouyel P
    Curr Opin Genet Dev; 2011 Jun; 21(3):295-301. PubMed ID: 21371880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders.
    Itzhaki RF; Wozniak MA
    Prog Lipid Res; 2006 Jan; 45(1):73-90. PubMed ID: 16406033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype influences vertical transmission of herpes simplex virus type 1 in a gender specific manner.
    Burgos JS; Ramirez C; Sastre I; Valdivieso F
    Aging Cell; 2007 Dec; 6(6):841-2. PubMed ID: 17725689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians.
    Piaceri I; Bagnoli S; Lucenteforte E; Mancuso M; Tedde A; Siciliano G; Piacentini S; Bracco L; Sorbi S; Nacmias B
    J Alzheimers Dis; 2011; 24(3):409-13. PubMed ID: 21297266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.
    Carter CJ
    Neurochem Int; 2007 Jan; 50(1):12-38. PubMed ID: 16973241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of Alzheimer's disease: an update.
    Brouwers N; Sleegers K; Van Broeckhoven C
    Ann Med; 2008; 40(8):562-83. PubMed ID: 18608129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study.
    Laumet G; Chouraki V; Grenier-Boley B; Legry V; Heath S; Zelenika D; Fievet N; Hannequin D; Delepine M; Pasquier F; Hanon O; Brice A; Epelbaum J; Berr C; Dartigues JF; Tzourio C; Campion D; Lathrop M; Bertram L; Amouyel P; Lambert JC
    J Alzheimers Dis; 2010; 20(4):1181-8. PubMed ID: 20413850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.